Myographic signals can effectively detect and assess subtle changes in muscle function; however, their measurement and analysis are often limited in clinical settings compared to inertial measurement units (IMUs). Recently, the advent of artificial intelligence (AI) has made the analysis of complex myographic signals more feasible. This scoping review aims to examine the use of myographic signals in conjunction with AI for assessing motor impairments, while also highlighting potential limitations and future directions. We conducted a systematic search using specific keywords in the Scopus and PubMed databases. After a thorough screening process, 111 relevant studies were selected for review. These studies were organized based on target applications (measurement modality, modality location, and AI model purpose/application), sample demographics (age, sex, ethnicity, and pathology), and AI models (general approach and algorithm type). Among the various myographic measurement modalities, surface electromyography (sEMG) was the most commonly used. In terms of AI approaches, machine learning with feature engineering was the predominant method, with classification tasks being the most common application of AI. Our review also noted a significant bias in participant demographics, with a greater representation of males compared to females and healthy individuals compared to patient groups. Overall, our findings suggest that integrating myographic signals with AI has the potential to provide more objective and clinically relevant assessments of motor impairments.

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; MH received payment of consulting fees from PDI Golf LLC a Texas Limited Liability Company; no other relationships or activities that could appear to have influenced the submitted work.

This study did not receive any funding.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors.